Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes.
Dialyzers are reused in approximately three quarters of the dialysis units in the United States, but the effect of reprocessing on dialyzer performance has not been extensively evaluated. In a crossover study of six chronic hemodialysis patients, we determined urea, creatinine, phosphate, and beta2-microglobulin clearances and dialysate protein loss for two types of low-flux and two types of high-flux dialyzers during use numbers 1, 2, 5, and 15. Dialyzers were reprocessed by an automated machine using Renalin (Renal Systems, Plymouth, MN) as the germicide. Dialyzer arterial and venous blood and dialysate outflow samples were obtained at 5 and 180 minutes of each dialysis session to evaluate solute clearances. Urea, creatinine, and phosphate clearances were calculated using dialysate concentrations, whereas beta2-microglobulin clearance was calculated using plasma concentrations to include its removal by adsorption to the dialysis membrane. There was a trend for urea, creatinine, and phosphate clearances to decrease with reuse for both low-flux and high-flux dialyzers, but these differences were not statistically significant. The clearance of beta2-microglobulin and dialysate total protein concentration was small for low-flux dialyzers; these values were not dependent on reuse. There was a trend for beta2-microglobulin clearance and dialysate total protein concentration to decrease during a dialysis treatment using high-flux dialyzers. More significantly, beta2-microglobulin clearance and dialysate total protein concentration decreased substantially with the reuse of high-flux dialyzers. These observations show that the maintenance of small solute clearances during reuse of high-flux dialyzers does not ensure the maintenance of large solute clearances.
Leypoldt
J K
JK
Department of Veterans Affairs Medical Center, Department of Internal Medicine, University of Utah, Salt Lake City 84112, USA. ken.leypoldt@hsc.utah.edu
Cheung
A K
AK
Deeter
R B
RB
D019342:Acetic Acid; D000328:Adult; D000368:Aged; D001783:Blood Flow Velocity; D003404:Creatinine / Q000097:blood; D015314:Dialysis Solutions / Q000737:chemistry; D004202:Disinfectants; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006861:Hydrogen Peroxide; D008297:Male; D008875:Middle Aged; D010463:Peracetic Acid; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis / Q000295:instrumentation* / Q000379:methods; D014462:Ultrafiltration; D014508:Urea / Q000097:blood; D001613:beta 2-Microglobulin / Q000032:analysis
D015314:Dialysis Solutions; D004202:Disinfectants; D004338:Drug Combinations; D010710:Phosphates; C117603:Renalin; D001613:beta 2-Microglobulin; D014508:Urea; D003404:Creatinine; D006861:Hydrogen Peroxide; D010463:Peracetic Acid; D019342:Acetic Acid